Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice

MLA

Richard Cathomas, et al. “Swiss Experience of Atezolizumab for Platinum-Pretreated Urinary Tract Carcinoma: The SAUL Study in Real-World Practice.” Swiss Medical Weekly, vol. 150, no. 1920, May 2020. EBSCOhost, https://doi.org/10.4414/smw.2020.20223.

APA

Richard Cathomas, Julian Schardt, Miklos Pless, Anna Llado, Nicolas Mach, Christian Riklin, Jenny Haefeli, Simon Fear, & Frank Stenner. (2020). Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice. Swiss Medical Weekly, 150(1920). https://doi.org/10.4414/smw.2020.20223

Chicago

Richard Cathomas, Julian Schardt, Miklos Pless, Anna Llado, Nicolas Mach, Christian Riklin, Jenny Haefeli, Simon Fear, and Frank Stenner. 2020. “Swiss Experience of Atezolizumab for Platinum-Pretreated Urinary Tract Carcinoma: The SAUL Study in Real-World Practice.” Swiss Medical Weekly 150 (1920). doi:10.4414/smw.2020.20223.